Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region

Rimke Bijker, JunYong Choi, Rossana Ditangco, Sasisopin Kiertiburanakul, Man Po Lee, Sarawut Siwamogsatham, Sanjay Pujari, Jeremy Ross, Chi Yuen Wong, Wing Wai Wong, Evy Yunihastuti, Matthew Law

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Introduction: Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. Materials and Methods: We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region. Results: Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope. Conclusion: Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIVpositive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.

Original languageEnglish
Pages (from-to)52-66
Number of pages15
JournalOpen AIDS Journal
Volume11
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Cardiovascular Diseases
HIV
Population
Guidelines
Risk Management
Disease Management
Dyslipidemias
Practice Guidelines
HIV Infections
Blood Glucose
Obesity
Smoking
Morbidity
Mortality
Incidence

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Virology

Cite this

Bijker, Rimke ; Choi, JunYong ; Ditangco, Rossana ; Kiertiburanakul, Sasisopin ; Lee, Man Po ; Siwamogsatham, Sarawut ; Pujari, Sanjay ; Ross, Jeremy ; Wong, Chi Yuen ; Wong, Wing Wai ; Yunihastuti, Evy ; Law, Matthew. / Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region. In: Open AIDS Journal. 2017 ; Vol. 11. pp. 52-66.
@article{e6882584f7304ac9aa4356642893dce6,
title = "Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region",
abstract = "Introduction: Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. Materials and Methods: We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region. Results: Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope. Conclusion: Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIVpositive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.",
author = "Rimke Bijker and JunYong Choi and Rossana Ditangco and Sasisopin Kiertiburanakul and Lee, {Man Po} and Sarawut Siwamogsatham and Sanjay Pujari and Jeremy Ross and Wong, {Chi Yuen} and Wong, {Wing Wai} and Evy Yunihastuti and Matthew Law",
year = "2017",
month = "8",
day = "1",
doi = "10.2174/1874613601711010052",
language = "English",
volume = "11",
pages = "52--66",
journal = "Open AIDS Journal",
issn = "1874-6136",
publisher = "Bentham Science Publishers B.V.",

}

Bijker, R, Choi, J, Ditangco, R, Kiertiburanakul, S, Lee, MP, Siwamogsatham, S, Pujari, S, Ross, J, Wong, CY, Wong, WW, Yunihastuti, E & Law, M 2017, 'Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region', Open AIDS Journal, vol. 11, pp. 52-66. https://doi.org/10.2174/1874613601711010052

Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region. / Bijker, Rimke; Choi, JunYong; Ditangco, Rossana; Kiertiburanakul, Sasisopin; Lee, Man Po; Siwamogsatham, Sarawut; Pujari, Sanjay; Ross, Jeremy; Wong, Chi Yuen; Wong, Wing Wai; Yunihastuti, Evy; Law, Matthew.

In: Open AIDS Journal, Vol. 11, 01.08.2017, p. 52-66.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region

AU - Bijker, Rimke

AU - Choi, JunYong

AU - Ditangco, Rossana

AU - Kiertiburanakul, Sasisopin

AU - Lee, Man Po

AU - Siwamogsatham, Sarawut

AU - Pujari, Sanjay

AU - Ross, Jeremy

AU - Wong, Chi Yuen

AU - Wong, Wing Wai

AU - Yunihastuti, Evy

AU - Law, Matthew

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Introduction: Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. Materials and Methods: We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region. Results: Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope. Conclusion: Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIVpositive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.

AB - Introduction: Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. Materials and Methods: We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region. Results: Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope. Conclusion: Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIVpositive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.

UR - http://www.scopus.com/inward/record.url?scp=85030779657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030779657&partnerID=8YFLogxK

U2 - 10.2174/1874613601711010052

DO - 10.2174/1874613601711010052

M3 - Review article

VL - 11

SP - 52

EP - 66

JO - Open AIDS Journal

JF - Open AIDS Journal

SN - 1874-6136

ER -